AlzChem Group AG (FRA:ACT)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.77B +77.8% |
| Revenue (ttm) | 575.05M +2.1% |
| Net Income | 63.46M +17.4% |
| EPS | 6.28 +18.1% |
| Shares Out | n/a |
| PE Ratio | 27.93 |
| Forward PE | 26.85 |
| Dividend | 2.10 (1.15%) |
| Ex-Dividend Date | May 6, 2026 |
| Volume | 773 |
| Average Volume | 453 |
| Open | 174.90 |
| Previous Close | 175.10 |
| Day's Range | 171.60 - 174.90 |
| 52-Week Range | 100.40 - 188.80 |
| Beta | n/a |
| RSI | 50.50 |
| Earnings Date | Apr 30, 2026 |
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silico... [Read more]
Financial Performance
In 2025, AlzChem Group AG's revenue was 575.05 million, an increase of 2.06% compared to the previous year's 563.44 million. Earnings were 63.46 million, an increase of 17.35%.
Financial StatementsNews
EQS-AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Alzchem Group AG / Preliminary announcement on the disclosure of financial statements Alzchem Group AG: Preliminary announcement of the publication of f...